Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Mertens

Showing results (121-130 of 211) with videos related to

Pageof 22
Sort By:
Annals of the Rheumatic Diseases|May 26, 2019
Low RUNX3 expression alters dendritic cell function in patients with systemic sclerosis and contributes to enhanced fibrosisAlsya J Affandi, Tiago Carvalheiro, Andrea Ottria, et al.
BJUI Compass|April 23, 2026
Barriers to pregnancy and parenthood during urology residency across EuropeLuca Afferi, Gaelle Margue, Carlos Toribio-Vázquez, et al.
International Urology and Nephrology|February 11, 2025
Key strategies for reducing recurrence in T1 bladder cancer. Evidence from a retrospective multicenter European studyRoberto Contieri, Alexandre Guigui, Bastien Gondran-Tellier, et al.
European Urology|March 21, 2025
European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2025 GuidelinesAntoine G van der Heijden, Harman Max Bruins, Albert Carrion, et al.
Future Oncology (London, England)|April 27, 2026
Mitomycin for intravesical treatment of low-grade intermediate-risk non-muscle invasive bladder cancerLudovica Cella, Alessio Finocchiaro, Aleksander Ślusarczyk, et al.
Cancer Immunology, Immunotherapy : CII|December 21, 2024
Target trial emulation to evaluate the effect of immune-related adverse events on outcomes in metastatic urothelial cancerRenate Pichler, Josef Fritz, Sarah Maier, et al.
European Urology|October 20, 2023
European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2023 GuidelinesJ Alfred Witjes, Harman Max Bruins, Albert Carrión, et al.
Actas Urologicas Espanolas|January 7, 2026
Efficacy and safety of active surveillance and chemoablation in the management of non-muscle invasive bladder cancer (NMIBC): Systematic review and pooled analysis by the European Association of Urology-Young Academic Urologists: Urothelial Carcinoma Working GroupA Saouli, R Contieri, F Quhal, et al.
European Urology Oncology|April 9, 2025
Oncological Outcomes in Bacillus Calmette-Guérin-naïve High-risk Non-muscle-invasive Bladder Cancer Patients: A Systematic Review on Current Treatment Strategies and Future PerspectivesMattia Longoni, Pietro Scilipoti, Francesco Soria, et al.
Cancers|June 10, 2023
Assessing the Performance of 18F-FDG PET/CT in Bladder Cancer: A Narrative Review of Current EvidenceMara Bacchiani, Vincenzo Salamone, Eleana Massaro, et al.
Pageof 22

Showing results (121-130 of 211) with videos related to

Sort By:
Pageof 22
Annals of the Rheumatic Diseases|May 26, 2019
Low RUNX3 expression alters dendritic cell function in patients with systemic sclerosis and contributes to enhanced fibrosisAlsya J Affandi, Tiago Carvalheiro, Andrea Ottria, et al.
BJUI Compass|April 23, 2026
Barriers to pregnancy and parenthood during urology residency across EuropeLuca Afferi, Gaelle Margue, Carlos Toribio-Vázquez, et al.
International Urology and Nephrology|February 11, 2025
Key strategies for reducing recurrence in T1 bladder cancer. Evidence from a retrospective multicenter European studyRoberto Contieri, Alexandre Guigui, Bastien Gondran-Tellier, et al.
European Urology|March 21, 2025
European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2025 GuidelinesAntoine G van der Heijden, Harman Max Bruins, Albert Carrion, et al.
Future Oncology (London, England)|April 27, 2026
Mitomycin for intravesical treatment of low-grade intermediate-risk non-muscle invasive bladder cancerLudovica Cella, Alessio Finocchiaro, Aleksander Ślusarczyk, et al.
Cancer Immunology, Immunotherapy : CII|December 21, 2024
Target trial emulation to evaluate the effect of immune-related adverse events on outcomes in metastatic urothelial cancerRenate Pichler, Josef Fritz, Sarah Maier, et al.
European Urology|October 20, 2023
European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2023 GuidelinesJ Alfred Witjes, Harman Max Bruins, Albert Carrión, et al.
Actas Urologicas Espanolas|January 7, 2026
Efficacy and safety of active surveillance and chemoablation in the management of non-muscle invasive bladder cancer (NMIBC): Systematic review and pooled analysis by the European Association of Urology-Young Academic Urologists: Urothelial Carcinoma Working GroupA Saouli, R Contieri, F Quhal, et al.
European Urology Oncology|April 9, 2025
Oncological Outcomes in Bacillus Calmette-Guérin-naïve High-risk Non-muscle-invasive Bladder Cancer Patients: A Systematic Review on Current Treatment Strategies and Future PerspectivesMattia Longoni, Pietro Scilipoti, Francesco Soria, et al.
Cancers|June 10, 2023
Assessing the Performance of 18F-FDG PET/CT in Bladder Cancer: A Narrative Review of Current EvidenceMara Bacchiani, Vincenzo Salamone, Eleana Massaro, et al.
Pageof 22